Description
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir) tablets is used for the treatment of patients with mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom’s macroglobulinemia.
Sofosbuvir/velpatasvir/voxilaprevir (trade name Vosevi) is a combination drug for the treatment of hepatitis C. It combines three drugs that each act by a different mechanism of action against the hepatitis C virus: sofosbuvir, velpatasvir, and voxilaprevir.
How can 1 go about obtaining VOSEVI ?
If VOSEVI (sofosbuvir, velpatasvir, and voxilaprevir) tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).
Note:
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
NEWS / UPDATES
- What are the best hepatitis C drugs? For More Details
- FDA approves Vosevi for Hepatitis C. For More Details